Nebulizer market size to surpass USD 1202.5 million by 2029

According to Fortune Business Insights, global nebulizer market size was valued at USD 833.6 million in 2021 and is projected to grow from USD 863.4 million in 2022 to USD 1,202.5 million by 2029, exhibiting a CAGR of 4.8% during the forecast period. Increasing respiratory disorders and robust demand for innovative respiratory drug delivery services are expected to elevate the market’s progress. Fortune Business Insights presents this information in its report titled “Nebulizer market forecast, 2022-2029”.

Key industry development
PARI Pharma GmbH declared the authorization of its LAMIRA Nebulizer System to deliver Insmed’s ARIKAYCE in Japan.

Key takeaways:

• The increasing incidence of respiratory disorders globally and the rising geriatric population are likely to fuel the market growth during the forecast period.
• Rapid adoption of nebulizer among the patient population is likely to drive their usage during the forecast period.
• The market size in North America stood at USD 382.7 million in 2021.

Discover the leading players featured in the report:
“Companies leading the Nebulizer market are OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), PARI Respiratory Equipment, Inc. (U.S.), DeVilbiss Healthcare LLC (U.S.), Briggs Healthcare (U.S.), GF HEALTH PRODUCTS, INC. (U.S.), Trudell Medical International (Canada), Allied Healthcare Products, Inc. (U.S.), Teleflex Medical, Inc. (U.S.).

Drivers and restraints
Rising respiratory disorders to propel market progress
Nebulizers are drug delivery devices that deliver medicines in the form of a mist in the lungs. Rising respiratory disorders are likely to foster the product adoption. For example, as per the Asthma and Allergy Foundation of America’s strategy, in April 2022, nearly 25.0 million people in the U.S. suffered from asthma. Poor air quality, rising pollution, and the presence of several factories are expected to foster the demand for the device. Furthermore, rising healthcare costs enhanced the adoption of home healthcare services, thereby elevating the demand for effective medical procedures and equipment. In addition, the robust demand for inhaled drug delivery devices is expected to drive the nebulizer market growth.

However, disease transmission risks and the availability of alternative treatment methods may hamper the market growth.

Segments
Jet segment to dominate attributable to its clinically proven advantages
By type, the market is segmented into jet, mesh, and ultrasonic. The jet segment is expected to lead due to its clinically proven benefits.

Table-top segment to lead owing to its unique characteristics
As per modality, the market is bifurcated into portable and table-top. The table-top segment is expected to lead due to the availability of reimbursement policies in developed markets, with operational benefits offered by these devices.

Homecare segment to dominate attributable to rising shift to medical devices
Based on end-user, the market is categorized into hospitals, clinics, and homecare settings. The homecare segment is expected to lead due to the rising shift toward medical devices.

Regionally, the market is clubbed into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Segmentation:
By type

• Jet nebulizer
• Ultrasonic nebulizer
• Mesh nebulizer

By modality

• Portable
• Table-top

By end-user

• Hospitals
• Clinics
• Homecare settings

By geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (South Africa, GCC Countries, Rest of the Middle East & Africa)

Regional insights
Higher prevalence of asthma to propel market progress in North America
North America is projected to dominate the nebulizer market share due to the higher prevalence of asthma. The market in North America stood at USD 382.7 million in 2021 and is expected to gain a huge portion of the global market share in the coming years. Furthermore, the higher prevalence of asthma is expected to enhance the demand for medical devices.

In Europe, the increasing prevalence of respiratory diseases and robust adoption of the device is expected to boost industry growth. Further, the rising prevalence of respiratory diseases is expected to enhance market progress.

In Asia Pacific, the increasing prevalence of chronic respiratory disorders is likely to elevate the demand for nebulizers. This factor may propel market progress in the region.

Competitive landscape
Crucial players deploy collaborations to enhance their brand image
The prominent companies operating in the market deploy acquisition strategies to enhance their brand image. For example, PARI GmbH partnered with TWT Digital Health (TWT) in July 2021 to develop the PARI connect application. This application also offers Bluetooth communication with the eTrack controller, a controller unit for PARI’s eFlow Technology nebulizer. Further, several players deploy research and development, mergers, acquisitions, partnerships, novel product launches, innovations, and industrial automation to enhance their market position. Fortune Business Insights™